| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.02 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.02 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |